Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "research"

3052 News Found

Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
News | June 15, 2026

Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers

Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise


Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026
News | June 14, 2026

Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026

Samelisant will be the centerpiece of Suven’s scientific presence


India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test
News | June 14, 2026

India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test

Cervical cancer remains one of the leading causes of cancer deaths among women in India


India validates first indigenous HPV DNA test for cervical cancer screening
Healthcare | June 13, 2026

India validates first indigenous HPV DNA test for cervical cancer screening

Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards


Ryvu advances romaciclib program as FDA clears AML trial expansion
Clinical Trials | June 13, 2026

Ryvu advances romaciclib program as FDA clears AML trial expansion

The regulatory decision follows promising results from RIVER-81


Rayat Bahra University, Shukra Pharma launch Rs. 10 lakh seed fund to back student startups
News | June 13, 2026

Rayat Bahra University, Shukra Pharma launch Rs. 10 lakh seed fund to back student startups

Partnership will provide funding, incubation, mentorship, and industry exposure for ventures in healthcare, pharmaceuticals, biotechnology, medical technology, and agriculture


Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
People | June 13, 2026

Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor

Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders


WHO SEARO, George Institute partner to advance AI-driven digital health solutions for NCDs
Public Health | June 13, 2026

WHO SEARO, George Institute partner to advance AI-driven digital health solutions for NCDs

Two-year collaboration aims to strengthen primary healthcare systems, generate real-world evidence, and support responsible adoption of AI and digital health technologies across South-East Asia


Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation


Parexel to showcase AI, real-world evidence and patient-centric innovations at DIA 2026
Clinical Trials | June 12, 2026

Parexel to showcase AI, real-world evidence and patient-centric innovations at DIA 2026

Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement